PLANET GREEN HOLDINGS CORP - Stock Price History | PLAG

Historical daily share price chart and data for PLANET GREEN HOLDINGS CORP since 2021 adjusted for splits. The latest closing stock price for PLANET GREEN HOLDINGS CORP as of September 23, 2021 is 1.16.
  • The all-time high PLANET GREEN HOLDINGS CORP stock closing price was 100.50 on January 19, 2010.
  • The PLANET GREEN HOLDINGS CORP 52-week high stock price is 3.50, which is 201.7% above the current share price.
  • The PLANET GREEN HOLDINGS CORP 52-week low stock price is 1.11, which is 4.3% below the current share price.
  • The average PLANET GREEN HOLDINGS CORP stock price for the last 52 weeks is 1.96.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
PLANET GREEN HOLDINGS CORP Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 2.4496 2.6000 4.1800 1.6535 2.2300 -18.61%
2019 3.6602 2.5226 5.3500 2.3706 2.7400 11.84%
2018 4.4590 4.6175 11.5100 1.9350 2.4500 -44.32%
2017 11.0844 13.5000 15.2500 4.1250 4.4000 -67.41%
2016 23.3295 30.0000 32.5000 13.0000 13.5000 -55.74%
2015 33.7515 25.0000 47.0000 23.7500 30.5000 28.42%
2014 27.6730 19.5000 32.5000 19.0000 23.7500 20.25%
2013 25.7985 32.0000 34.7500 17.0275 19.7500 -38.29%
2012 32.3240 43.5000 43.5000 25.7500 32.0025 -19.99%
2011 48.0719 65.0000 72.2500 31.2500 40.0000 -38.70%
2010 76.1059 74.5000 100.5000 62.5000 65.2500 -14.43%
2009 69.8949 66.2500 83.5000 58.7500 76.2500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.035B $0.004B
Planet Green Holdings Corp is a biotechnology enterprise. It provides artificial intelligence integrates extraction, R&D, production and sales from natural plants. Planet Green Holdings Corp., formerly known as American Lorain Corporation, is based in China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71